Used primarily in pharmaceutical research, 6-(Methylamino)nicotinamide serves as a key intermediate in the synthesis of various bioactive compounds. Its structure is valuable in developing molecules with potential therapeutic effects, particularly in the areas of neurology and oncology. Researchers utilize it to explore treatments for neurodegenerative diseases and cancer, focusing on its role in modulating cellular pathways. Additionally, it is studied for its potential in enhancing drug efficacy and reducing side effects in targeted therapies.